المؤلفون: Kılıçkap, Saadettin, Öztürk, Akın, Karadurmuş, Nuri, Korkmaz, Taner, Yumuk, Perran Fulden, Çiçin, İrfan, Paydaş, Semra, Çılbır, Ebru, Şakalar, Teoman, Uysal, Mükremin, Yeşil Çınkır, Havva, Üskent, Necdet, Demir, Necla, Sakin, Abdullah, Dursun, Oldaç Uras, Aver, Birkan, Turhal, Nazım Serdar, Keskin, Serkan, Tural, Deniz, Eralp, Yeşim, Buğdaycı Başal, Fatma, Yaşar, Hatime Arzu, Şendur, Mehmet Ali Nahit, Demirci, Umut, Çubukçu, Erdem, Karaağaç, Mustafa, Çakar, Burcu, Tatlı, Ali Murat, Yetişyiğit, Tarkan, Urvay, Semiha, Gürsoy, Pınar, Oyan, Başak, Turna, Zeynep Hande, Işıkdoğan, Abdurrahman, Ölmez, Ömer Fatih, Yazıcı, Ozan, Çabuk, Devrim, Şeker, Mehmet Metin, Ünal, Olçun Ümit, Meydan, Nezih, Okutur, Sadi Kerem, Tunalı, Didem, Erman, Mustafa

مصطلحات موضوعية: Lung Cancer Patients, ALK

وصف الملف: application/pdf

العلاقة: Medicine (United States); Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Kılıçkap, S., Öztürk, A., Karadurmuş, N., Korkmaz, T., Yumuk, P. F., Çiçin, İ. . Erman, M. (2024). A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy. Medicine (United States), 103(21), E37972. http://dx.doi.org/10.1097/MD.0000000000037972Test; http://dx.doi.org/10.1097/MD.0000000000037972Test; https://hdl.handle.net/20.500.12511/12613Test; 103; 21; E37972; Q2; 001230616700060; 2-s2.0-85194219961; Q3

الإتاحة: https://doi.org/20.500.12511/1261310.1097/MD.0000000000037972Test
https://hdl.handle.net/20.500.12511/12613Test

المؤلفون: Şenocak Taşçı, Elif, Oyan, Başak, Sönmez, Özlem, Mutlu, Arda Ulaş, Atçı, Muhammed Mustafa, Sakin, Abdullah, Öner, İrem, Yeşil Çınkır, Havva, Bozkurt, Mustafa

مصطلحات موضوعية: Metastatic Colorectal Cancer, Chemotherapy, Regorafenib, Third-Line Treatment

وصف الملف: application/pdf

العلاقة: BMC Cancer; Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı; Şenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atçı, M. M., Sakin, A. . Bozkurt, M. (2024). Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024). BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-024-11863-0Test; https://dx.doi.org/10.1186/s12885-024-11863-0Test; https://hdl.handle.net/20.500.12511/12264Test; 24; Q2; 001148300200002

الإتاحة: https://doi.org/20.500.12511/12264Test
https://doi.org/10.1186/s12885-024-11863-0Test
https://hdl.handle.net/20.500.12511/12264Test

المؤلفون: Şenocak Taşçı, Elif, Oyan, Başak, Sönmez, Özlem, Mutlu, Arda Ulaş, Atçı, Muhammed Mustafa, Sakin, Abdullah, Öner, İrem, Yeşil Çınkır, Havva, Karakurt Eryılmaz, Melek, Çağlayan, Dilek, Balçık, Onur Yazdan, Paksoy, Nail, Bozkurt, Mustafa

مصطلحات موضوعية: Colon Cancer, Fluouracil, Rechallenge, Regorafenib, Survival, Third-Line Treatment

وصف الملف: application/pdf

العلاقة: BMC Cancer; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Şenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atçı, M. M., Sakin, A. . Bozkurt, M. (2024). Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer. BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-023-11783-5Test; https://dx.doi.org/10.1186/s12885-023-11783-5Test; https://hdl.handle.net/20.500.12511/12141Test; 24; 2-s2.0-85181247540; Q1

الإتاحة: https://doi.org/20.500.12511/12141Test
https://doi.org/10.1186/s12885-023-11783-5Test
https://hdl.handle.net/20.500.12511/12141Test

المؤلفون: SÜTCÜOĞLU, OSMAN, ÖZET, AHMET, Yeşil Çinkir, Havva, Aktaş, Gökmen, Dirikoç, Merve, Akkuş, Gülsüm, Kuş, Tülay, Yalçintaş Arslan, Ülkü, Köse, Fatih, Yildirim Özdemir, NURİYE

العلاقة: 4fd79cc0-617d-4579-ae44-8db77522b6d0; https://avesis.gazi.edu.tr/publication/details/4fd79cc0-617d-4579-ae44-8db77522b6d0/oaiTest

الإتاحة: https://doi.org/10.37047/jos.2022-90537Test
https://avesis.gazi.edu.tr/publication/details/4fd79cc0-617d-4579-ae44-8db77522b6d0/oaiTest

المؤلفون: Şenocak Taşçı, Elif, Oyan, Başak, Sönmez, Özlem, Mutlu, Arda Ulaş, Atcı, Muhammed Mustafa, Sakin, Abdullah, Öner, İrem, Yeşil Çınkır, Havva, Karakurt Eryılmaz, Melek, Çağlayan, Dilek, Yazdan Balçık, Onur, Paksoy, Nail, Bozkurt, Mustafa

مصطلحات موضوعية: Colon Cancer, Fluouracil, Rechallenge, Regorafenib, Survival, Third-Line Treatment

وصف الملف: application/pdf

العلاقة: BMC Cancer; Diğer; Şenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atcı, M. M., Sakin, A. . Bozkurt, M. (2024). Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (BMC Cancer, (2024), 24, 1, (16), 10.1186/s12885-023-11783-5). BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-024-11863-0Test; https://dx.doi.org/10.1186/s12885-024-11863-0Test; https://hdl.handle.net/20.500.12511/12240Test; 24; 2-s2.0-85182828807; Q1

الإتاحة: https://doi.org/20.500.12511/12240Test
https://doi.org/10.1186/s12885-024-11863-0Test
https://doi.org/10.1186/s12885-023-11783-5Test).
https://hdl.handle.net/20.500.12511/12240Test

المؤلفون: Isbilen, Elif, Kus, Tulay, Yesil Cinkir, Havva, Aktas, Gokmen, Buyukbebeci, Aysegul

المصدر: Turkish Journal of Biochemistry ; volume 46, issue 5, page 509-516 ; ISSN 1303-829X

الإتاحة: https://doi.org/10.1515/tjb-2021-0137Test

المؤلفون: Semiz, Hüseyin Salih, Yavuzşen, Tuğba, Ekinci, Ferhat, Erdoğan, Atike Pınar, Kuş, Fatih, Yıldırım, Hasan Çağrı, Aksoy, Sercan, Karataş, Fatih, Bayram, Ertuğrul, Karaboyun, Kubilay, Yeşil Çınkır, Havva, Yıldırım, Nilgün, Karakurt Eryılmaz, Melek, Türkmen Bekmez, Esra, Alan, Özkan, Özçelik, Melike, Düzköprü, Yakup, Imamoğlu, Gökçen Inanç, Sakalar, Teoman, Ak, Naziye, İlhan, Yusuf, Turhal, Serdar, Ellez, Halil İbrahim

العلاقة: bc1820fb-8311-424f-a0e9-4b38f47300a0; https://avesis.deu.edu.tr/publication/details/bc1820fb-8311-424f-a0e9-4b38f47300a0/oaiTest

الإتاحة: https://avesis.deu.edu.tr/publication/details/bc1820fb-8311-424f-a0e9-4b38f47300a0/oaiTest

المؤلفون: Kılıçkap, Saadettin, Demirci, Umut, Buğdaycı, Fatma, Tural, Deniz, Korkmaz, Taner, Paydaş, Semra, Yılmaz, Coşkun, Tuna, Hande, Sezer, Ahmet, Yeşil Çinkir, Havva, Erman, Münire, Eralp, Yeşim, Çabuk, Devrim, Işıkdoğan, Abdurrahman, Demirkazık, Ahmet, Karaoğlu, Aziz, Yazılıtaş, Doğan, Çay Şenler, Filiz, Yumuk, Perran Fulden, Coşkun, Hatice, Yıldız, İbrahim, Öztop, İlhan, Beypınar, İsmail, Aydın, Kübra, Kaplan, M., Meydan, Nezih, Ölmez, Ömer Fatih, Seber, Samile, Arslan, Çağatay, Şendur, Mehmet Ali Nahit, Çiçin, İrfan

مصطلحات موضوعية: ALK Positive, ROS1 Positive, Lorlatinib, Advanced Stage Lung Cancer

وصف الملف: application/pdf

العلاقة: Journal of Thoracic Oncology; Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı; Kılıçkap, S., Demirci, U., Buğdaycı, F., Tural, D., Korkmaz, T., Paydaş, S. . Çiçin, İ. (2019). Lorlatinib in ALK- or ROS1-positive non-small cell lung cancer patients: Experience from an early access program in Turkey. Journal of Thoracic Oncology içinde (S558-S559. ss.). Elsevier Science. https://doi.org/10.1016/j.jtho.2019.08.1166Test; https://doi.org/10.1016/j.jtho.2019.08.1166Test; https://hdl.handle.net/20.500.12511/4670Test; 14; 10; S558; S559; Q1

الإتاحة: https://doi.org/20.500.12511/4670Test
https://doi.org/10.1016/j.jtho.2019.08.1166Test
https://hdl.handle.net/20.500.12511/4670Test

المؤلفون: Peled, Nir, Gillis, Roni, Kılıçkap, Saadettin, Froesch, Patrizia, Orlov, Sergei, Filippova, Elena, Demirci, Umut, Christopoulos, Petros, Çiçin, İrfan, Buğdaycı Basal, Fatma, Yılmaz, Cengiz, Fedor, Moiseenko, Korkmaz, Taner, Paydaş, Semra, Gautschi, Oliver, Zırtıloğlu, Alişan, Eralp, Yeşim, Yeşil Çınkır, Havva, Sezer, Ahmet, Erman, Mustafa, Tural, Deniz, Turna, Hande, Mazieres, Julien, Dudnik, Elizabeth, Reguart, Noemi, Camidge, David Ross, Ng, Terry L., Çay Şenler, Filiz, Beypınar, İsmail, Yazılıtaş, Doğan, Demirkazık, Ahmet, Karaoğlu, Aziz, Okutur, Kerem, Coşkun, Hasan Şenol, Şendur, Mehmet Ali Nahit, Işıkdoğan, Abdurrahman, Çabuk, Devrim, Yumuk, Perran Fulden, Yıldız, İbrahim, Kaplan, Mehmet Ali, Özyılkan, Özgür, Öztop, İlhan, Ölmez, Ömer Fatih, Aydın, Kübra, Aydıner, Adnan, Meydan, Nezih, Grinberg, Roxana Denisa, Roisman, Laila C.

مصطلحات موضوعية: Lorlatinib, Real-World Data, ALK, ROS1

وصف الملف: application/pdf

العلاقة: Lung cancer; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Peled, N., Gillis, R., Kılıçkap, S., Froesch, P., Orlov, S., Filippova, E. . Roisman, L. C. (2020). Glass: Global lorlatinib for ALK(+) and ROS1(+) retrospective study: Real world data of 123 NSCLC patients. Lung cancer, 148, 48-54. https://dx.doi.org/10.1016/j.lungcan.2020.07.022Test; https://dx.doi.org/10.1016/j.lungcan.2020.07.022Test; https://hdl.handle.net/20.500.12511/5930Test; 148; 48; 54; Q1

الإتاحة: https://doi.org/20.500.12511/5930Test
https://doi.org/10.1016/j.lungcan.2020.07.022Test
https://hdl.handle.net/20.500.12511/5930Test

المؤلفون: Ilhan, Gül, Ahmed, Fahad, Ören, Ayse Ceyda, Akbayram, Sinan, Harputluoglu, Hakan, Ural, Cihan, Sengelen, Meltem, Ayyildiz, Orhan, Aktas, Gökmen, Kirazli, Meral, ŞAHİN, BERKSOY, Kutluk, Tezer, Uçar, Mehmet Ali, Ebinç, Senar, Güvenç, Birol, BAYRAM, İBRAHİM, Aydin, Sinem, Yesil Çinkir, Havva, SEZGİN, GÜLAY, Isikdogan, Abdurrahman, Yalçin, Suayib, Köse, Dogan, Acipayam, Can, Üzel, Veysiye Hülya, Sullivan, Richard, Söker, Murat, Akyay, Arzu, Güncan, Sabri, Erçolak, Vehbi, Akdeniz, Aydan, Berber, Ilhami, Sasmaz, Ilgen, Okan, Vahap

العلاقة: 69bdae95-2390-4e2c-8f3d-95362f30d6c7; https://avesis.hacettepe.edu.tr/publication/details/69bdae95-2390-4e2c-8f3d-95362f30d6c7/oaiTest

الإتاحة: https://doi.org/10.1001/jamanetworkopen.2023.12903Test
https://avesis.hacettepe.edu.tr/publication/details/69bdae95-2390-4e2c-8f3d-95362f30d6c7/oaiTest